MENU
CLRB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Cellectar Biosciences (CLRB) Earnings Date & Reports
Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company... Show more
Industry: #Biotechnology
A.I. Advisor
published Earnings
CLRB is expected to report earnings to fall 19.30% to -46 cents per share on November 12
Q3'26
Est.
$-0.46
Q2'26
Missed
by $0.09
Q1'26
Missed
by $1.13
Q4'25
Missed
by $1.15
Q3'25
Missed
by $1.27
The last earnings report on August 13 showed earnings per share of -56 cents, missing the estimate of -47 cents. With 41.66K shares outstanding, the current market capitalization sits at 11.06M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
a biopharmaceutical company that is engaged in developing compounds for the treatment and imaging of cancer
Industry Biotechnology
Industry
Biotechnology
Address
100 Campus Drive
Phone
+1 608 441-8120
Employees
11
Web
https://www.cellectar.com